Equity Profile
Pre-Earnings Brief
ICON PLC is a leading provider of outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. With a market cap of $8 billion, the company plays a crucial role in the healthcare sector, particularly in life sciences tools and services, which are increasingly important as the demand for innovative therapies grows.
Earnings Per Share (EPS)
EPS is a key indicator of the company's profitability and is closely watched by investors.
Revenue Growth
Revenue growth reflects the company's ability to expand its business and capture market share in a competitive industry.
1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.
ICON PLC is a leading provider of outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. With a market cap of $8 billion, the company plays a crucial role in the healthcare sector, particularly in life sciences tools and services, which are increasingly important as the demand for innovative therapies grows.
EPS Beat Streak
4Q
EPS Beat Rate
88%
Avg EPS Surprise
+3.85%
Avg Stock Reaction
+0.85%
In Q3 2025, ICON reported an EPS of $3.31, exceeding expectations by 5.41%. However, the stock experienced a slight decline of 0.34% the following day, indicating mixed investor sentiment despite the earnings beat.
Management Promises & Guidance
Overall, expectations for ICON's upcoming earnings report are cautious, given the lack of analyst estimates and management guidance. Investors are keen to see if the company can maintain its recent trend of beating earnings expectations.
Bull Case
If ICON continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially leading to a positive stock reaction.
Bear Case
Conversely, any signs of declining revenue or client retention could raise concerns about the company's growth prospects, leading to a negative reaction in the stock.
Earnings Per Share (EPS)
N/AEPS is a key indicator of the company's profitability and is closely watched by investors.
Revenue Growth
N/ARevenue growth reflects the company's ability to expand its business and capture market share in a competitive industry.
Client Retention Rate
N/AThis metric indicates how well ICON maintains relationships with its clients, which is vital for sustained revenue.
Expectations
The print will turn on these two things.
Q1
What is the EPS for Q4-2025?
The EPS figure will be critical in determining if ICON can maintain its trend of beating expectations, which could influence investor sentiment.
Q2
How has client retention changed over the past quarter?
Client retention is vital for ICON's long-term growth, and any decline could signal potential challenges ahead.
Edge
Why consensus could be wrong
The Street may underestimate ICON's ability to maintain high client retention rates, which are crucial for sustained revenue growth. Recent operational improvements may not be fully reflected in current expectations.
Supporting Evidence
ICON has consistently beaten EPS estimates in the past, indicating strong operational execution.
The company's commitment to technology investments could enhance service delivery and client satisfaction.
Recent trends in the healthcare sector suggest increased demand for outsourced services.
Key Risk
If client retention rates show significant improvement, it could lead to upward revisions in growth expectations.
Edge
Pre-commit to what would confirm each case.
This quarter's performance is pivotal as it will show whether ICON can sustain its growth trajectory amidst a competitive landscape.
Bull Confirmed If
An EPS of $3.50 or higher would confirm strong operational performance and growth potential.
Bear Confirmed If
An EPS below $3.10 could indicate declining profitability and raise concerns about future growth.
Pre-Earnings Positioning
Implied Move
±N/A
Historical Avg
±1.2%
There is currently no options market data available to gauge investor sentiment leading up to the earnings report.
Options are pricing ±4.0% while ICLR has averaged ±1.2% over the last 8 prints — setup is pricing rich.
30d HV
44.7%
Edge
Cross-company pattern from 30 similar setups.
Prior-quarter beat setup in Health Care
n=30Fade rate: 7 of 20 (35%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 20 (65%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 6.0%, with a raw directional average of +2.4% (modestly positive historical bias).
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If ICON beats expectations, history suggests the stock could rise by around 1.10%, confirming strong operational performance and investor confidence.
In-Line / Cautious
If results are in line with previous quarters, the stock may see muted movement as investors await further guidance.
Miss
A miss could lead to a decline of approximately 0.96%, raising concerns about the company's growth prospects.
Preparation
House & Senate STOCK Act disclosures over the trailing 6 months.
Trades
2
0 buys·2 sells
Members
2
House only
Est. Notional
$101,002.00–$265,000.00
disclosed dollar ranges
Most Active Members
1 trade
Net selling
1 trade
Net selling
Recent Transactions
Traded Mar 5, 2026 · disclosed Apr 3, 2026
$100,001.00–$250,000.00
Traded Feb 12, 2026 · disclosed Mar 12, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
DOMINOS PIZZA INC